Injured Myocardium-Targeted Theranostic Nanoplatform for Multi-Dimensional Immune-Inflammation Regulation in Acute Myocardial Infarction.

Adv Sci (Weinh) · 2025 · PMC11904987 · PMID 39836506

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

While immune cell membrane‐based biomimetic nanomedicines demonstrate potential to evade immune surveillance during systemic circulation, our findings indicate a decreasing trend in the hepatic accumulation of HM4oRL NPs.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.